Posted on July 16, 2018 by Sitemaster
A newly published paper in Prostate Cancer and Prostatic Diseases has confirmed that there is an association between specific forms of androgen deprivation therapy (ADT) and certain types of adverse thromboembolic events. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, adverse, androgen, deprivation, DVT, event, PE, risk, thromboembolism | 3 Comments »
Posted on December 2, 2014 by Sitemaster
Yesterday we commented (by request) on a paper by Klotz et al. suggesting that initial treatment with the LHRH antagonist degarelix might have benefits compared to initial treatment with an LHRH agonist such as leuprolide or goserelin acetate. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse, Degarelix, event, LHRH agonist, outcome, trreatment | 1 Comment »
Posted on May 15, 2009 by Sitemaster
“Liminality” and “biographical disruption” are not terms familiar to the average prostate cancer patient — unless perhaps that patient is a social anthropologist. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, event, limnal, transformative | Leave a comment »